"The fully enclosed Pavilion provides an immersive experience on the history, evolution, and future ofphotomedicine, including CLINUVEL’s development program with the novel drug SCENESSE®(afamelanotide) to treat vitiligo."
Ann: CLINUVEL Unveils Vitiligo Program for AAD 2025, page-6
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$9.85 |
Change
0.040(0.41%) |
Mkt cap ! $493.7M | |||
| Open | High | Low | Value | Volume |
| $9.90 | $10.00 | $9.82 | $407.0K | 41.07K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 100 | $9.85 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $9.87 | 409 | 6 |
View Market Depth
| Last trade - 13.41pm 17/06/2025 (20 minute delay) ? |
| CUV (ASX) Chart |